Precise, simplified diagnostic criteria and optimised management of initial-onset Vogt-Koyanagi-Harada disease: an updated review.

Abstract

Vogt-Koyanagi-Harada (VKH) disease is a primary autoimmune stromal choroiditis. This review aimed to provide a novel perspective of the disease. We took into account recent developments in the understanding of the disease and crucial progress in investigational modalities of the choroid, which has led to new, simpler diagnostic criteria. We analysed recent novel notions in the literature and new diagnostic tools for VKH. We identified the following updates for VKH disease: (1) A crucial differentiation between the acute initial-onset and the chronic forms of the disease; (2) the integration of new, precise imaging methods to assess choroidal inflammation; (3) the promotion of simplified, more reliable diagnostic criteria for acute initial-onset of the disease, based on the sine qua non presence of diffuse choroiditis, detected with indocyanine green angiography (ICGA) and/or Enhanced Depth Imaging OCT (EDI-OCT); and (4) treatment optimisation through early, vigorous, sustained corticosteroid and nonsteroidal immunosuppression, as the first line of treatment for initial-onset VKH disease, and monitoring subclinical choroidal inflammation during follow-ups. Several studies have shown that most patients could discontinue treatment without an inflammation relapse. ICGA and EDI-OCT represented the methods of choice for precisely monitoring disease evolution. Simplified, precise, new diagnostic criteria allow early diagnosis of VKH. In VKH disease, inflammation exclusively originates in the choroidal stroma. Therefore, in many cases, early, sustained treatment, with dual corticosteroid and nonsteroidal immunosuppressive therapy can result in full "healing", which obviates chronic, uncontrolled, subclinical choroidal inflammation.

• Authors: Carl P Herbort Jr, Ilknur Tugal-Tutkun, Ahmed Abu-El-Asrar, Amod Gupta, Masaru Takeuchi, Christine Fardeau, Alireza Hedayatfar, Cristhian Urzua, Ioannis Papasavvas
• Journal: Eye (London, England) (Eye (Lond)) Vol. 36 Issue 1 Pg. 29-43 (01 2022) ISSN: 1476-5454 [Electronic] England
• PMID: 34145419 (Publication Type: Journal Article, Review)
• Copyright: © 2021. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.

Chemical References

• Adrenal Cortex Hormones

Topics

• Adrenal Cortex Hormones (therapeutic use)
• Choroid
• Choroiditis (diagnosis, drug therapy)
• Fluorescein Angiography (methods)
• Humans
• Inflammation (drug therapy)
• Uveomeningoencephalitic Syndrome (diagnosis, drug therapy)